Status:
UNKNOWN
Evaluating Lip Repositioning for the Treatment of Excess Gingival Display With and Without Pretreatment With Botox
Lead Sponsor:
Cairo University
Conditions:
Gingival Overgrowth
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Since the introduction of the lip repositioning procedure by a number of modifications to the technique have been introduced. All these modifications were made to prevent the main complication of lip ...
Detailed Description
Normal gingival display has been defined by as the gum exposure between the inferior border of upper lip and gingival margin of anterior central incisors when smiling. An exposure of gingiva around 0-...
Eligibility Criteria
Inclusion
- Gummy smile more than 3mm.
- Adults \>18 years.
- Non-smokers.
- Patients with healthy systemic condition
- Normal clinical crown dimensions.
- Good oral hygiene.
Exclusion
- Natural dentition upper anterior
- Pregnant or lactating women.
- Patients with inflamed gingiva or gingival enlargement.
- Inflammation or infection at the site of injection.
- Patients with allergy to botulinum toxin, lactose, and albumin.
- Concurrent use of aminoglycoside antibiotic that enhances the action of the toxin. (Jaspers, Pijpe, \& Jansma, 2011)
- \< 3 mm attached gingivae that might create difficulties in flap design, stabilization and suturing.
- Patients using anticholinesterase or other agents interfering with neuromuscular transmission
Key Trial Info
Start Date :
September 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04030767
Start Date
September 20 2019
End Date
September 20 2022
Last Update
July 24 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.